NVIDIA and Lilly Launch AI Co-Innovation Lab for Next-Generation Drug Discovery
NVIDIA and Lilly launch a $1 billion AI co-innovation lab in San…
Compliance Officer, Boehringer Ingelheim IMETA (India, Middle East, Turkey, Africa)
Hani Hussein is a seasoned compliance leader with over 25 years of…
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company…
Lilly names Roberta Marinelli as new President & GM for Middle East & Türkiye.
Lilly has appointed Roberta Marinelli as the President and General Manager for…
Lilly and EVA Pharma launch locally made Insulin in Egypt
December 2024- The Egyptian Drug Authority approved the insulin glargine injection manufactured…
‘‘We Want To Become The Most Digital And AI-driven Company In Our Industry’’ – Thierry Bernard
Taking the time to have a productive discussion with experts yields insightful…
Lilly expands manufacturing footprint in Ireland
September 2024- Eli Lilly and Company announced a $1 billion expansion of…
Could single-Dose Zepbound Vials be a game-changer for weight loss?
August 2024- Eli Lilly and Company announced Zepbound ® (tirzepatide) 2.5 mg…
Tirzepatide Cuts Type 2 Diabetes Risk by 94% in Adults with Pre-Diabetes and Obesity
INDIANAPOLIS- Eli Lilly and Company announced today positive topline results from the SURMOUNT-1…
Lilly and OpenAI Team Up Against Superbugs
June 2024- Eli Lilly and Company announced a collaboration with OpenAI that…
